Efficacy of Oral Zinc Therapy in Epidermodysplasia Verruciformis with Squamous Cell Carcinoma

Overview

Journal Indian Dermatol Online J

Specialty Dermatology

Date 2014 Mar 12

PMID 24616858

Citations 6

Authors

Sudhanshu Sharma

Krishna Deb Barman

Rashmi Sarkar

Mukesh Manjhi

Vijay Kumar Garg

Affiliations

Soon will be listed here.

Abstract

Epidermodysplasia verruciformis (EV) is a rare, inherited disorder that predisposes patients to widespread human papillomavirus (HPV) infection and cutaneous squamous cell carcinomas. There is still no definitive therapeutic modality for EV. A 24 year old male patient with EV was treated with oral zinc sulphate, one of the cheapest and safe immuno-modulator available as therapeutic agent with satisfactory result.

Citing Articles

A Case Report of Epidermodysplasia Verruciformis: Clinical Presentation and Histopathological Features.

Alenazi A, Alraddadi B, Alharbi A Cureus. 2024; 16(7):e65249.

PMID: 39184733 PMC: 11342291. DOI: 10.7759/cureus.65249.

Trace element zinc and skin disorders.

Zou P, Du Y, Yang C, Cao Y Front Med (Lausanne). 2023; 9:1093868.

PMID: 36733937 PMC: 9887131. DOI: 10.3389/fmed.2022.1093868.

Intralesional Candida albicans antigen versus intralesional zinc sulfate in treatment of cutaneous warts.

Youssef E, Eissa M, Bakr R Arch Dermatol Res. 2022; 315(5):1305-1314.

PMID: 36567351 PMC: 10205831. DOI: 10.1007/s00403-022-02499-w.

Epidermodysplasia Verruciformis: A Rare Case Report.

Alshammari R, Al-Issa A, Ghobara Y Cureus. 2020; 12(7):e9046.

PMID: 32782865 PMC: 7410503. DOI: 10.7759/cureus.9046.

Cryotherapy plus oral zinc sulfate versus cryotherapy plus placebo to treat common warts: A double blind, randomized, placebo-controlled trial.

Mahmoudi H, Ghodsi S, Tavakolpour S, Daneshpazhooh M Int J Womens Dermatol. 2018; 4(2):87-90.

PMID: 29872682 PMC: 5986231. DOI: 10.1016/j.ijwd.2017.09.004.

References

Kitamura H, Morikawa H, Kamon H, Iguchi M, Hojyo S, Fukada T . Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat Immunol. 2006; 7(9):971-7. DOI: 10.1038/ni1373. View

Sun X, Chen J, Xu A . A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis. Clin Exp Dermatol. 2005; 30(5):573-4. DOI: 10.1111/j.1365-2230.2005.01858.x. View

Androphy E, Dvoretzky I, Lowy D . X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred. Arch Dermatol. 1985; 121(7):864-8. View

Mun J, Kim S, Jung D, Ko H, Kim B, Kwon K . Oral zinc sulfate treatment for viral warts: an open-label study. J Dermatol. 2011; 38(6):541-5. DOI: 10.1111/j.1346-8138.2010.01056.x. View

Al-Waiz M, Sharquie K . Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br J Dermatol. 2002; 146(3):423-31. DOI: 10.1046/j.1365-2133.2002.04617.x. View

Micali G, Nasca M, dallOglio F, Musumeci M . Cimetidine therapy for epidermodysplasia verruciformis. J Am Acad Dermatol. 2003; 48(2 Suppl):S9-10. DOI: 10.1067/mjd.2003.111. View

Ansarin H, Tajziehchi L, Shaianfar N . A case of epidermodysplasia verruciformis with squamous cell carcinomas on non-sun-exposed areas of skin. Arch Iran Med. 2007; 10(2):261-3. DOI: 07102/AIM.0027. View

Mcdermott D, Gammon B, Snijders P, Mbata I, Phifer B, Howland Hartley A . Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation. Pediatr Dermatol. 2009; 26(3):306-10. PMC: 3398466. DOI: 10.1111/j.1525-1470.2008.00853.x. View

Stefani M, Bottino G, Fontenelle E, Azulay D . [Efficacy comparison between cimetidine and zinc sulphate in the treatment of multiple and recalcitrant warts]. An Bras Dermatol. 2009; 84(1):23-9. DOI: 10.1590/s0365-05962009000100003. View

10.

Heratizadeh A, Volker B, Kupsch E, Wichmann K, Kapp A, Werfel T . [Successful symptomatic treatment of epidermodysplasia verruciformis with imiquimod 5% cream]. Hautarzt. 2010; 61(12):1052-5. DOI: 10.1007/s00105-010-1998-4. View

11.

Gober M, Rady P, He Q, Tucker S, Tyring S, Gaspari A . Novel homozygous frameshift mutation of EVER1 gene in an epidermodysplasia verruciformis patient. J Invest Dermatol. 2006; 127(4):817-20. DOI: 10.1038/sj.jid.5700641. View

12.

Yaghoobi R, Sadighha A, Baktash D . Evaluation of oral zinc sulfate effect on recalcitrant multiple viral warts: a randomized placebo-controlled clinical trial. J Am Acad Dermatol. 2009; 60(4):706-8. DOI: 10.1016/j.jaad.2008.09.010. View

13.

Lazarczyk M, Pons C, Mendoza J, Cassonnet P, Jacob Y, Favre M . Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med. 2007; 205(1):35-42. PMC: 2234378. DOI: 10.1084/jem.20071311. View